A 28-year-old man from Delhi presents to the emergency department with a 2-day history of high-grade fever, severe headache, neck stiffness, and photophobia. On examination, he is febrile (39.5°C), has positive Kernig's and Brudzinski's signs, and a petechial rash over the trunk and extremities. Blood culture is pending. CSF analysis shows: WBC 450/μL (85% neutrophils), protein 180 mg/dL, glucose 35 mg/dL (serum glucose 120 mg/dL), Gram stain shows Gram-negative diplococci. What is the most appropriate immediate antibiotic regimen?

Explanation

## Clinical Diagnosis This is a case of **bacterial meningitis** with clinical and CSF features consistent with **Neisseria meningitidis** (meningococcal meningitis). ### Key CSF Findings | Parameter | Finding | Interpretation | |-----------|---------|----------------| | Cell count | 450/μL | Bacterial range (typically 100–10,000/μL) | | Predominant cell | 85% neutrophils | Acute bacterial infection | | Protein | 180 mg/dL | Elevated (bacterial: >100 mg/dL) | | Glucose | 35 mg/dL (CSF:serum ratio ~0.29) | Low (bacterial: <0.4) | | Gram stain | Gram-negative diplococci | Neisseria meningitidis | | Clinical sign | Petechial rash | Pathognomonic for meningococcemia | ### Antibiotic Selection **Key Point:** Empiric meningitis therapy in India must cover both *Streptococcus pneumoniae* and *Neisseria meningitidis*. Although Gram stain identifies meningococci, **vancomycin is added empirically** because: 1. **Penicillin resistance** in *S. pneumoniae* is increasing in India and globally. 2. **Ceftriaxone** penetrates CSF well and covers both organisms. 3. **Vancomycin** is added to ensure coverage of penicillin-resistant pneumococci (PRSP) until susceptibilities are known. **High-Yield:** The standard empiric regimen for bacterial meningitis in adults in India is: - **Ceftriaxone 2 g IV 6-hourly** (or 4 g 12-hourly) PLUS - **Vancomycin 15–20 mg/kg IV 8–12-hourly** (target trough 15–20 μg/mL) **Clinical Pearl:** Dexamethasone 10 mg IV should be given **before or with the first antibiotic dose** to reduce mortality and neurological sequelae, especially in meningococcal meningitis. ### Why Ceftriaxone + Vancomycin? 1. **Ceftriaxone** alone may fail if PRSP is present (resistance emerging in India). 2. **Vancomycin** ensures CSF penetration and covers resistant strains. 3. This combination is **guideline-standard** for empiric meningitis therapy (WHO, CDC, Indian guidelines). 4. Once susceptibilities are known, vancomycin can be de-escalated if the organism is penicillin-susceptible. **Mnemonic:** **CVPM** — **C**eftriaxone + **V**ancomycin + **P**enetration + **M**eningitis. [cite:Harrison 21e Ch 381]